Envista

Envista

Yahoo Finance • 4 days ago

Envista Holdings (NVST), Why Is Investor Attention Building Now?

Envista Holdings (NVST) is set to present at the 2026 Global Healthcare Conference in New York on September 15, giving investors fresh commentary to weigh against recent share performance and fundamentals. Envista Holdings enters the conf... Full story

Yahoo Finance • 7 days ago

Should Value Investors Buy Envista (NVST) Stock?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growt... Full story

Yahoo Finance • 7 days ago

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)

Envista (NVST) has been beaten down lately with too much selling pressure. While the stock has lost 12% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect th... Full story

Yahoo Finance • 7 days ago

3 Profitable Stocks That Fall Short

3 Profitable Stocks That Fall Short While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, "Your margin is my o... Full story

Yahoo Finance • 16 days ago

NVST or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are... Full story

Yahoo Finance • 22 days ago

Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Macquarie upgraded Broadcom (AVGO) to... Full story

Yahoo Finance • 22 days ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More

Quick Read Broadcom, Deere, and Dell all earned Outperform upgrades Thursday, with analyst price targets set at $490, $813, and $625 respectively. Moderna was cut to Sell with an $81 target, while Ultragenyx's price target was halved to $... Full story

Yahoo Finance • 28 days ago

4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI

As August draws to a close, the stock market is hovering near record levels, even as elevated Treasury yields, persistent inflation concerns and softer economic signals add to uncertainty. At the same time, recent gains have been heavily c... Full story

Yahoo Finance • 29 days ago

3 Healthcare Stocks We Steer Clear Of

3 Healthcare Stocks We Steer Clear Of From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare st... Full story

Yahoo Finance • 29 days ago

Best Momentum Stocks to Buy for August 27th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 27: Onto Innovation Inc. ONTO: This manufacturer of process control tools for optical metrology has a Zacks Rank #1 and witnes... Full story

Yahoo Finance • last month

Envista (NVST): Buy, Sell, or Hold Post Q2 Earnings?

Envista (NVST): Buy, Sell, or Hold Post Q2 Earnings? Over the past six months, Envista's shares (currently trading at $27.36) have posted a disappointing 7.6% loss, well below the S&P 500's 10.5% gain. This may have investors wondering ho... Full story

Yahoo Finance • 2 months ago

Envista Q2 Earnings Call Highlights

Key Points Interested in Envista Holdings Corporation? Here are five stocks we like better. Strong second-quarter performance: Envista reported $731 million in sales, up just over 7% year over year, with 5% core growth. Adjusted EBITDA ro... Full story

Yahoo Finance • 2 months ago

1 Profitable Stock with Impressive Fundamentals and 2 We Question

1 Profitable Stock with Impressive Fundamentals and 2 We Question Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it wil... Full story

Yahoo Finance • 3 months ago

Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren BMO Capital Markets named Intuitive Surgical (ISRG [https://seekingalpha.com/symbol/ISRG]), Globus Medical (GMED [https://seekingalpha.com/symbol/GMED]), and Telefle... Full story

Yahoo Finance • 3 months ago

Is Envista Holdings Corporation (NVST) a Top Ariel Investment Stock to Buy?

Envista Holdings Corporation (NYSE:NVST) is one of the top stocks to buy according to Ariel Investments. On June 11, Barclays reiterated an Overweight rating on Envista Holdings Corporation (NYSE:NVST) but lowered the price target to $32 f... Full story

Yahoo Finance • 3 months ago

The John Rogers Contrarian Playbook: How Envista, MSG Entertainment, and Smucker Stack Up for Retirement Investors

Quick Read SJM yields 3.91% at 12x forward earnings with a beta of 0.264, while NVST pays no dividend and trades at 66x trailing PE. Smucker's free cash flow surged 42% to $1.16B in FY2026, backing 27-plus consecutive years of quarterly d... Full story

Yahoo Finance • 4 months ago

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The r... Full story

Yahoo Finance • 5 months ago

Envista Holdings Corp. (NVST) Jumps on Earnings Beat as Market Share Gains Accelerate

Ariel Investments, an investment management company, released its “Ariel Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined 1.48% in the quarter, underperforming both the Russell 2500 Value and Ru... Full story

Yahoo Finance • 6 months ago

Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings

[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story

Yahoo Finance • 6 months ago

Data center cooling demand will outlast AI bubble, Ecolab says

(Bloomberg) — The company behind a $4.75 billion data-center cooling deal said demand for its services will keep growing even if the buildout of artificial intelligence infrastructure slows down. Ecolab Inc., which agreed last week to buy... Full story